Home › Research › Tau biomarkers
CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment
Stefani A, Martorana A, Bernardini S, Panella M, Mercati F, Orlacchio A, Pierantozzi M.. Journal of the neurological sciences, 2006-11-09
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Standard markers in cerebrospinal fluid (CSF), as soluble amyloid beta 1-42 (Abeta1-42) and total tau protein (t-tau), may contribute to dementia subtypes diagnostic accuracy. Yet, their sensitivity to assess the different degree of cognitive deficit is not fully clarified. Our study analyses Abeta1-42 and t-tau CSF levels in different cohorts of Alzheimer's disease (AD) patients, distinguished as early AD (mild cognitively impaired subjects recently converted to AD), mild AD (MMSE or =18), and moderately advanced AD (MMSE<18).
What this study adds
Evidence grade: Low
This study analyzed Aβ1-42 and total tau cerebrospinal fluid levels across groups of Alzheimer's disease patients with different degrees of cognitive impairment. It found these markers were not related to the different degree of cognitive impairment, and it concerns diagnosis rather than treatment, cure, or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Stefani, A., Martorana, A., Bernardini, S., Panella, M., Mercati, F., Orlacchio, A., et al. (2006). CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment. Journal of the neurological sciences. https://doi.org/10.1016/j.jns.2006.09.014
Vancouver
Stefani A, Martorana A, Bernardini S, Panella M, Mercati F, Orlacchio A, et al. CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment. Journal of the neurological sciences. 2006. doi:10.1016/j.jns.2006.09.014. PMID: 17097109.
BibTeX
@article{stefani2006-17097109,
author = {Stefani, A. and Martorana, A. and Bernardini, S. and Panella, M. and Mercati, F. and Orlacchio, A. and Pierantozzi, M.},
title = {{CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment}},
journal = {Journal of the neurological sciences},
year = {2006},
doi = {10.1016/j.jns.2006.09.014},
pmid = {17097109},
url = {https://doi.org/10.1016/j.jns.2006.09.014}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Yet, their sensitivity to assess the different degree of cognitive deficit is not fully clarified.
- Our study analyses Abeta1-42 and t-tau CSF levels in different cohorts of Alzheimer's disease (AD) patients, distinguished as early AD (mild cognitively impaired subjects recently converted to AD), mild AD (MMSE or =18), and moderately advanced AD (MMSE<18).
- The control group was represented by age-matched patients affected by depressive pseudo-dementia.
- Reduced Abeta1-42 and increased t-tau CSF levels were confirmed as hallmarks of AD at any disease stage.
Why it matters
This study analyzed Aβ1-42 and total tau cerebrospinal fluid levels across groups of Alzheimer's disease patients with different degrees of cognitive impairment. It found these markers were not related to the different degree of cognitive impairment, and it concerns diagnosis rather than treatment, cure, or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Journal of the neurological sciences) |
| Journal's citation record | 2 / 4 | Journal of the Neurological Sciences: journal h-index 233 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2006 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 59 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.7 citations a year over 22 year(s) since 2006 |
| Impact for its field and year | 3 / 6 | Cited 4.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 10 other studies in this library |
| Still being cited | 1 / 4 | Cited 7 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Mariangela Pierantozzi: h-index 50 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Sapienza University of Rome: institution h-index 1,145 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 17097109) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Later studies that cite this one
10 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.